Emerging two-dimensional materials-based diagnosis of neurodegenerative diseases: Status and challenges

Abstract Neurodegenerative diseases (NDs), conventionally characterized by multifarious impacts on patients’ cognitive skill, motor function and memory, have been brought into focus with the aging tendency worldwide. Accurate and sensitive diagnosis is a sine qua non for effective therapies, but unfortunately, there still remain insufficient approaches to identifying the occurrence of NDs at clinical frontline and laboratory. Furthermore, most diagnostic methods, such as PET, MRI, ELISA, etc. are generally expensive and time-consuming. Based on this status quo, promising two-dimensional (2D) materials, with ultrathin atomic layer structure (one or several atoms thick generally) and huge specific surface area, have been researched to overcome those shortcomings owing to their extraordinary performances. The idea of integrating 2D materials and biomolecules provides inspiration for the development of the detection of various sensitive pathological substances. The atomic-level construction of biological probes with 2D materials can be an effective method for precise control of the sensing process, thus optimizing various performances of detection methods. This review provides some representative researches concerning how current 2D materials can shorten reaction time and elevate sensitivity via modifying electrodes, shortening quenching time and triggering signal amplification to elevate the properties of diagnostic methods. Here we summarize current strategies and challenges for 2D material-based applications of NDs to provide a clue to overcome the formidable obstacles in early diagnosis.

[1]  Junjian Zhang,et al.  Hypoxia Inducible Factor 1α Promotes Endogenous Adaptive Response in Rat Model of Chronic Cerebral Hypoperfusion , 2017, International journal of molecular sciences.

[2]  Jungkyun Oh,et al.  Ultrasensitive and Selective Organic FET-type Nonenzymatic Dopamine Sensor Based on Platinum Nanoparticles-Decorated Reduced Graphene Oxide. , 2017, ACS applied materials & interfaces.

[3]  Yi Cui,et al.  Energy storage: The future enabled by nanomaterials , 2019, Science.

[4]  Lin Mei,et al.  Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy. , 2019, ACS nano.

[5]  Shenshu Yang,et al.  ROS and diseases: role in metabolism and energy supply , 2019, Molecular and Cellular Biochemistry.

[6]  Yao-Xin Lin,et al.  Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance. , 2019, Nano letters.

[7]  A. Bishayee,et al.  Report on Second International Conference on Natural Products for Cancer Prevention and Therapy Held in Kayseri, Turkey, 8–11 November 2017 , 2017, Nutrients.

[8]  Junle Qu,et al.  Ultrathin 2D Nonlayered Tellurium Nanosheets: Facile Liquid‐Phase Exfoliation, Characterization, and Photoresponse with High Performance and Enhanced Stability , 2018 .

[9]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[10]  Andreas Frutiger,et al.  Ultra Stable Molecular Sensors by Submicron Referencing and Why They Should Be Interrogated by Optical Diffraction—Part II. Experimental Demonstration , 2020, Sensors.

[11]  R. Yuan,et al.  Determination of Alzheimer biomarker DNA by using an electrode modified with in-situ precipitated molybdophosphate catalyzed by alkaline phosphatase-encapsulated DNA hydrogel and target recycling amplification , 2019, Microchimica Acta.

[12]  P. Chu,et al.  Black‐Phosphorus‐Incorporated Hydrogel as a Sprayable and Biodegradable Photothermal Platform for Postsurgical Treatment of Cancer , 2018, Advanced science.

[13]  M. G. Savelieff,et al.  Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors. , 2017, Chemical Society reviews.

[14]  Pu Wang,et al.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau , 2021, International journal of molecular sciences.

[15]  P. Calabresi,et al.  Amyloid-β: a potential link between epilepsy and cognitive decline , 2021, Nature Reviews Neurology.

[16]  M. Geschwind,et al.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. , 2018, Cold Spring Harbor perspectives in biology.

[17]  K. Blennow,et al.  Biomarkers for Alzheimer's disease: current status and prospects for the future , 2018, Journal of internal medicine.

[18]  Y. Chen,et al.  Neurotensin‐Conjugated Reduced Graphene Oxide with Multi‐Stage Near‐Infrared‐Triggered Synergic Targeted Neuron Gene Transfection In Vitro and In Vivo for Neurodegenerative Disease Therapy , 2016, Advanced healthcare materials.

[19]  O. Muskens,et al.  Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer's Disease and Prostate Cancer. , 2017, ACS sensors.

[20]  Pandiyarasan Veluswamy,et al.  Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@erGO) nanocomposite for selective detection of Parkinson's disease biomarker. , 2018, Biosensors & bioelectronics.

[21]  Chia-Liang Sun,et al.  Synthesis of short graphene oxide nanoribbons for improved biomarker detection of Parkinson's disease. , 2015, Biosensors & bioelectronics.

[22]  D. Eisenberg,et al.  Propagation of Tau Aggregates and Neurodegeneration. , 2017, Annual review of neuroscience.

[23]  M. Zaretskaia,et al.  Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer’s disease , 2021, Neuroscience Letters.

[24]  M. Tsimidou,et al.  Special Issue “Saffron (Crocus sativus, L.): Omics and Other Techniques in Authenticity, Quality, and Bioactivity Studies” , 2016, Molecules.

[25]  Münteha Nur Sonuç Karaboğa,et al.  Analysis of Tau-441 protein in clinical samples using rGO/AuNP nanocomposite-supported disposable impedimetric neuro-biosensing platform: Towards Alzheimer's disease detection. , 2020, Talanta.

[26]  S. S. Sinha,et al.  Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer's Disease Biomarkers. , 2015, ACS applied materials & interfaces.

[27]  R. Kukreti,et al.  Oxidative Stress: A Key Modulator in Neurodegenerative Diseases , 2019, Molecules.

[28]  S. Strack,et al.  Mitochondrial dynamics in neuronal injury, development and plasticity , 2017, Journal of Cell Science.

[29]  J. Andersen,et al.  Mechanisms of SOD1 regulation by post-translational modifications , 2019, Redox biology.

[30]  Laurence Eaves,et al.  High electron mobility, quantum Hall effect and anomalous optical response in atomically thin InSe. , 2017, Nature nanotechnology.

[31]  A. Nouvenne,et al.  Uric Acid and Cognitive Function in Older Individuals , 2018, Nutrients.

[32]  Tae Hoon Lee,et al.  ZnO nanowire arrays on 3D hierachical graphene foam: biomarker detection of Parkinson's disease. , 2014, ACS nano.

[33]  Han Zhang,et al.  Two-Dimensional Black Phosphorus Nanomaterials: Emerging Advances in Electrochemical Energy Storage Science , 2020, Nano-micro letters.

[34]  P. Shaw,et al.  The role of mitochondria in amyotrophic lateral sclerosis , 2017, Neuroscience Letters.

[35]  A. Musto,et al.  The role of inflammation in the development of epilepsy , 2018, Journal of Neuroinflammation.

[36]  P. Carloni,et al.  Structural Determinants of the Prion Protein N-Terminus and Its Adducts with Copper Ions , 2018, International journal of molecular sciences.

[37]  Y. Joseph,et al.  Structure–Function Relationships of Nanocarbon/Polymer Composites for Chemiresistive Sensing: A Review , 2021, Sensors.

[38]  F. Zhang,et al.  Revealing of the ultrafast third-order nonlinear optical response and enabled photonic application in two-dimensional tin sulfide , 2019, Photonics Research.

[39]  M. Walker Pathophysiology of status epilepticus , 2016, Neuroscience Letters.

[40]  D. Hulisz Amyotrophic lateral sclerosis: disease state overview. , 2018, The American journal of managed care.

[41]  Yao-Xin Lin,et al.  Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments , 2018, Advanced science.

[42]  C. Jack,et al.  Alzheimer's disease: The next frontier—Special Report 2017 , 2017, Alzheimer's & Dementia.

[43]  Ramón Cacabelos,et al.  Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.

[44]  M. Filip,et al.  Oxidative Stress in Neurodegenerative Diseases , 2015, Molecular Neurobiology.

[45]  Dianyuan Fan,et al.  2D Nonlayered Selenium Nanosheets: Facile Synthesis, Photoluminescence, and Ultrafast Photonics , 2017 .

[46]  M. Hayes Parkinson's Disease and Parkinsonism. , 2019, The American journal of medicine.

[47]  K. Yung,et al.  Roles of Glutamate Receptors in Parkinson’s Disease , 2019, International journal of molecular sciences.

[48]  P. Chu,et al.  Surface Coordination of Black Phosphorus for Robust Air and Water Stability. , 2016, Angewandte Chemie.

[49]  E. Wild,et al.  Huntington's Disease Clinical Trials Corner: March 2020. , 2020, Journal of Huntington's disease.

[50]  Huaiyu Wang,et al.  Few-Layered Black Phosphorus: From Fabrication and Customization to Biomedical Applications. , 2018, Small.

[51]  Xionghui Wei,et al.  Carbon-Based Nanocomposites as Fenton-Like Catalysts in Wastewater Treatment Applications: A Review , 2021, Materials.

[52]  Weiran Ye,et al.  A sensitive detection assay based on signal amplification technology for Alzheimer's disease's early biomarker in exosome. , 2018, Analytica chimica acta.

[53]  Hyunjoon Kong,et al.  Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. , 2019, Biomaterials.

[54]  K. Blennow,et al.  Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. , 2020, JAMA.

[55]  D. Panagiotakos,et al.  Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease , 2017, Nutritional neuroscience.

[56]  P. Chu,et al.  Near-infrared light control of bone regeneration with biodegradable photothermal osteoimplant. , 2019, Biomaterials.

[57]  Yinyi Sun,et al.  Autophagy and inflammation in ischemic stroke , 2020, Neural regeneration research.

[58]  Zhen Yuan,et al.  The effect of V‐ATPase function defects in pathogenesis of Alzheimer's disease , 2018, CNS neuroscience & therapeutics.

[59]  A. Atri The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. , 2019, The Medical clinics of North America.

[60]  Tae Geun Kim,et al.  Enhancing surface functionality of reduced graphene oxide biosensors by oxygen plasma treatment for Alzheimer's disease diagnosis. , 2017, Biosensors & bioelectronics.

[61]  Wei Cheng,et al.  NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. , 2019, Angewandte Chemie.

[62]  Shen-ming Chen,et al.  Ultrasound-assisted synthesis of α-MnS (alabandite) nanoparticles decorated reduced graphene oxide hybrids: Enhanced electrocatalyst for electrochemical detection of Parkinson's disease biomarker. , 2019, Ultrasonics sonochemistry.

[63]  Sonja W. Scholz,et al.  Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.

[64]  Michelle Grayson Parkinson's disease , 2016, Nature.

[65]  Josep Ferré-Borrull,et al.  A photoelectrochemical sandwich immunoassay for protein S100β, a biomarker for Alzheimer’s disease, using an ITO electrode modified with a reduced graphene oxide-gold conjugate and CdS-labeled secondary antibody , 2019, Microchimica Acta.

[66]  O. Forlenza,et al.  Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium , 2021, Neuroscience Letters.

[67]  A. Pliss,et al.  Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor , 2020 .

[68]  K. Blennow,et al.  Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts , 2020, The Lancet Neurology.

[69]  Saptarshi Das,et al.  Mimicking Neurotransmitter Release in Chemical Synapses via Hysteresis Engineering in MoS2 Transistors. , 2017, ACS nano.

[70]  Josemir W. Sander,et al.  Epilepsy is a neurological and a systemic disorder , 2018, Epilepsy & Behavior.

[71]  M. Sabbagh,et al.  Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 , 2021, The Journal of Prevention of Alzheimer's Disease.

[72]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[73]  A. Mamun,et al.  Toxic tau: structural origins of tau aggregation in Alzheimer's disease , 2020, Neural regeneration research.

[74]  M. Rahaie,et al.  A nanobiosensor based on graphene oxide and DNA binding dye for multi-microRNAs detection , 2019, Bioscience reports.

[75]  Y. Liu,et al.  Recent advances in black phosphorus-based electrochemical sensors: A review. , 2021, Analytica chimica acta.

[76]  L. Alvarez,et al.  Lignans from Bursera fagaroides Affect In Vivo Cell Behavior by Disturbing the Tubulin Cytoskeleton in Zebrafish Embryos , 2018, Molecules.

[77]  D. Fan,et al.  Few‐Layer Tin Sulfide: A Promising Black‐Phosphorus‐Analogue 2D Material with Exceptionally Large Nonlinear Optical Response, High Stability, and Applications in All‐Optical Switching and Wavelength Conversion , 2018 .

[78]  T. Davis,et al.  Regulation of blood–brain barrier integrity by microglia in health and disease: A therapeutic opportunity , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[79]  C. Frost,et al.  A Metabolic Study of Huntington’s Disease , 2016, PloS one.

[80]  E. Pop,et al.  Ultrahigh thermal isolation across heterogeneously layered two-dimensional materials , 2019, Science Advances.

[81]  E. Ruppin,et al.  Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility , 2019, Neuron.

[82]  K. Ghaedi,et al.  Huntington’s Disease and Mitochondria , 2017, Neurotoxicity Research.

[83]  Wendy Noble,et al.  Roles of tau protein in health and disease , 2017, Acta Neuropathologica.

[84]  Paul M. Thompson,et al.  Age, APOE and sex: Triad of risk of Alzheimer’s disease , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[85]  X. Qu,et al.  Label-free ratiometric electrochemical detection of the mutated apolipoprotein E gene associated with Alzheimer's disease. , 2016, Chemical communications.

[86]  P. Abete,et al.  Oxidative stress, aging, and diseases , 2018, Clinical interventions in aging.

[87]  M. Tremblay,et al.  Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress , 2018, Neurobiology of Stress.

[88]  G. Koelsch BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology , 2017, Molecules.

[89]  H. Tian,et al.  Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease. , 2014, ACS applied materials & interfaces.